3-rx.comCustomer Support3-rx.com
Find a product
    HomeAbout UsFAQContactHelp
 
   
 
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics
Online Pharmacy



Pregnancy is the period from conception to birth. A pregnancy may be complicated by health problems or lifestyle issues known as risk factors. These risk factors can affect the mother or fetus, or both


Join our Mailing List

Men`s Health sites at Top100biz.com




Syndicate

You are here : 3-RX.com > Home > Cancer -

Hormone level linked to colorectal cancer risk

CancerNov 19, 05

Low levels of a hormone secreted by fat cells, independent of body mass index (BMI)—a measure of Obesity—are associated with an increased risk of colorectal cancer in men, according to a report in the Journal of the National Cancer Institute.

Previous reports have linked body fat and insulin resistance with colorectal cancer risk. Since adiponectin, an insulin-related hormone secreted by fat cells, is inversely associated with both these factors, Dr. Esther K. Wei, from Harvard Medical School in Boston, and colleagues hypothesized that it too would be tied to the risk of this malignancy.

The analysis involved 18,225 men who participated in the Health Professionals Follow-up Study. Adiponectin levels were measured in blood samples given in 1994 and the subjects were followed through 2002 to identify cases of colorectal cancer. For risk determination, the patients who developed colorectal cancer were matched to two control subjects by birth year and date of blood draw.

During follow-up, 179 men developed colorectal cancer. Men with the highest adiponectin levels were 52 percent less likely to develop this cancer than their peers with the lowest levels. Moreover, factoring in BMI and other major risk factors for colorectal cancer had little effect on the strength of this association.

“There’s been more and more evidence that (fat) tissue isn’t just inert, that it’s actually secreting hormones,” Wei told Reuters Health. “So it may be involved in disease processes.”

“The fact that the link between adiponectin levels and colorectal cancer risk remained after accounting for BMI, suggests that it’s not simply a proxy measure of body fatness,” Wei said.

“Studies are needed to investigate this association in women,” Wei added. “In general, BMI is not as strongly tied to colorectal cancer in women as in men. Also, adiponectin levels differ between the sexes, so it’s possible that the association seen in men does not apply to women.”

SOURCE: Journal of the National Cancer Institute, November 16, 2005.



Print Version
Tell-a-Friend

RELATED ARTICLES:
  U.S. study weighs lifetime risks from CT scans
  Cancer patients’ race may affect well-being
  New statistical model could help reduce breast-lesion biopsies
  Testing for cancer at home
  Tamoxifen easier on the brain than thought: study
  Cancer incidence and mortality drops among American men and women, according to annual report
  Iressa Proves Just as Effective as Chemotherapy for Lung Cancer
  Latinas more likely to regret breast cancer treatment decisions
  Cancer survival rates impact type of Web communities used by patients
  No Protective Effect on Cancer from Long-Term Vitamin E or Vitamin C Supplementation
  Genetics of aging and cancer resistance
  Scientists unravel breast cancer drug resistance

 


Advertisement
















Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site